BioBeam™ 660 Acne Light Therapy, a Low-Level Narrow Band Red Light Medical Device for Treatment of Acne, is Now Available

Share Article

Introducing the BioBeam™ 660 acne lamp -- a drug free, pain free, risk free, low level narrow band red light medical device clinically proven to treat all types of acne for young and adults. The BioBeam™ 660 is a small handheld device sold as a OTC device for use at home. It emits a low power red light (660nm) which does not emits heat and does not hurt or burn your tissues. BioBeam™ 660 is not a laser device but emitts Low Level Narrow Band Red Light both at Continuous Wave (CW) and/or Pulse Wave (PW). The light albeit non-coherent is still effective for the treatment of Acne and related skin problems. Therefore BioBeam™ 660 provides all the benefits of lasers yet at much lower price.

Introducing the BioBeam™ 660 - a drug free, pain free, risk free, low level narrow band red light medical device clinically proven to treat all types of acne for young and adults. The BioBeam™ 660 is a small handheld device sold as a OTC device for use at home. It emits a low power red light (660nm) which does not emits heat and does not hurt or burn your tissues.

BioBeam™ 660 is not a laser device but emitts Low Level Narrow Band (LLNB) Red Light both at Continuous Wave (CW) and/or Pulse Wave (PW). The light albeit non-coherent is still effective for the treatment of Acne and related skin problems. Therefore BioBeam™ 660 provides all the benefits of lasers yet at much lower price.

BioBeam™ 660 is a Class 2A phototherapeutic medical device and complies with Annex VI of the Medical Device Directive 93/42/EEC and is CE certified (CE 0473). BioBeam™ 660 has been found to be a fast and effective treatment for acne. Recommended illumination is 1-2 times a day, six minutes on each area. The device is lightweight and portable and can be used anytime anywhere, at home or in the ofice.

A double blind clinical study by Dr Earon Gideon - Earon Clinics and Dr Avikamharel of the Pediatric Dermatology Outpatients Clinic in Dana Medical Center, Ichilov Hospital Israel clearly demonstrated the efficacy of the BioBeam™ 660. The results of these works were presented by Dr. Avikam Harel and Dr. Gideon Earon at the 6th International Conference of Pediatric Dermatology in Toronto in 1992 and were enthusiastically received in medical circles. Patients in the study all suffered from Acne Vulgaries, with comedones and pustules on their face and a feeling of inflammation. After six weeks of treatment the following encouraging results were recorded:

20% - complete recovery

50% - almost complete recovery

20% - considerable improvement

Nodules cure was very significant (p=.02) and comedones cure was significant (P=.05).

Just 10% of patients showed no improvement

The BioBeam™ 660 is a phototherapy device. Phototherapy, the use of light for healing, has been a field of rigorous research for 40 years, and light's curative properties are well documented. During the last several years, accelerated research performed by NASA has confirmed what many have asserted. For the past two decades, the medical properties of light have been investigated rigorously, both in the laboratory and in the clinic, to delineate its mechanisms and potential clinical applications. This work has proven that LLNB light alters a number of cellular processes, including protein synthesis, cell growth and differentiation, cell motility, membrane potential and binding affinities, neurotransmitter release, ATP synthesis, and others, similar to photosynthesis in plants. Further, different wavelengths have been shown to produce different healing effects at the biochemical, cellular, histological, and functional levels.

For more information visit http://www.dermalogix.net

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Timothy Chan Yew Kwong